Delivery Order SPE2DB20D3103-SPE2DB22FP3D9

Award Date 7/26/22
Potential Completion Date 7/27/22
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,325.50 firm fixed price delivery order is for the supply of Mupirocin 2% Cream 15GM, a topical antibiotic medication. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by parent company Cencora, Inc. The $2,152.21 delivery order is for the supply of Mupirocin 2% Cream, a topical antibiotic medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream 30GM. The contract has a ceiling value of $7,764.41 and an ultimate completion date of December 1, 2023. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $10,379.87 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565662415 - Mupirocin 2% Cream 15GM. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide. The...
This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $8,618.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Ointment 22GM, a topical antibiotic medication. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,256.96 Firm Fixed Price Delivery Order is for the supply of Mupirocin 2% Cream, a pharmaceutical product, with a period of performance ending on February 13, 2024. The award is not associated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
The U.S. Defense Logistics Agency (DLA) awarded a $2,747.52 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565760585 - Mupirocin 2% Ointment 22GM. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, SPE2DB20D3505|SPE2DB24FU2A2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.20 Firm Fixed Price Delivery Order is for the supply of Mupirocin 2% Cream, a pharmaceutical product, with a completion date of May 2, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FT24N, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,510.06 firm fixed-price delivery order is for the provision of 4560731683 - Mupirocin 2% Cream 15GM, a pharmaceutical product. The contract has an ultimate completion date of April 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP3D9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,494.32 firm fixed-price delivery order is for the supply of Mupirocin 2% Cream in 15 gram tubes. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary contracting vehicle for critical medical commodities including specialty medications, generic drugs, vaccines, syringes, and test kits. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 for similar medical products and prescription drugs.

Generated 2/27/25, 12:44 PM